Literature DB >> 19696434

Selective expansion of HIV-1 envelope glycoprotein-specific B cell subsets recognizing distinct structural elements following immunization.

Pia Dosenovic1, Bimal Chakrabarti, Martina Soldemo, Iyadh Douagi, Mattias N E Forsell, Yuxing Li, Adhuna Phogat, Staffan Paulie, James Hoxie, Richard T Wyatt, Gunilla B Karlsson Hedestam.   

Abstract

The HIV-1 envelope glycoprotein (Env) functional spike has evolved multiple immune evasion strategies, and only a few broadly neutralizing determinants on the assembled spike are accessible to Abs. Serological studies, based upon Ab binding and neutralization activity in vitro, suggest that vaccination with current Env-based immunogens predominantly elicits Abs that bind nonneutralizing or strain-restricted neutralizing epitopes. However, the fractional specificities of the polyclonal mixture of Abs present in serum, especially those directed to conformational Env epitopes, are often difficult to determine. Furthermore, serological analyses do not provide information regarding how repeated Ag inoculation impacts the expansion and maintenance of Env-specific B cell subpopulations. Therefore, we developed a highly sensitive Env-specific B cell ELISPOT system, which allows the enumeration of Ab-secreting cells (ASC) from diverse anatomical compartments directed against different structural determinants of Env. In this study, we use this system to examine the evolution of B cell responses in mice immunized with engineered Env trimers in adjuvant. We demonstrate that the relative proportion of ASC specific for defined structural elements of Env is altered significantly by homologous booster immunizations. This results in the selective expansion of ASC directed against the variable regions of Env. We suggest that the B cell specificity and compartment analysis described in this study are important complements to serological mapping studies for the examination of B cell responses against subspecificities of a variety of immunogens.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696434     DOI: 10.4049/jimmunol.0900407

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  An engineered mutant of HIV-1 gp120 formulated with adjuvant Quil A promotes elicitation of antibody responses overlapping the CD4-binding site.

Authors:  Fatima K Ahmed; Brenda E Clark; Dennis R Burton; Ralph Pantophlet
Journal:  Vaccine       Date:  2011-12-04       Impact factor: 3.641

2.  Critical roles of chemokine receptor CCR10 in regulating memory IgA responses in intestines.

Authors:  Shaomin Hu; KangKang Yang; Jie Yang; Ming Li; Na Xiong
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

Review 3.  Role of adjuvants in modeling the immune response.

Authors:  Darrick Carter; Steven G Reed
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

4.  Irreversible phenotypic perturbation and functional impairment of B cells during HIV-1 infection.

Authors:  Jingjing Yan; Shuye Zhang; Jun Sun; Jianqing Xu; Xiaoyan Zhang
Journal:  Front Med       Date:  2017-11-27       Impact factor: 4.592

5.  Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood.

Authors:  Giulietta Saletti; Nicolas Çuburu; Jae Seung Yang; Ayan Dey; Cecil Czerkinsky
Journal:  Nat Protoc       Date:  2013-05-09       Impact factor: 13.491

6.  Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies.

Authors:  Jidnyasa Ingale; Karen Tran; Leopold Kong; Barna Dey; Krisha McKee; William Schief; Peter D Kwong; John R Mascola; Richard T Wyatt
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

7.  HIV-1 envelope glycoprotein trimer immunogenicity elicited in the presence of human CD4 alters the neutralization profile.

Authors:  Mattias N E Forsell; Krisha McKee; Yu Feng; John R Mascola; Richard T Wyatt
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11       Impact factor: 2.205

8.  Influence of novel CD4 binding-defective HIV-1 envelope glycoprotein immunogens on neutralizing antibody and T-cell responses in nonhuman primates.

Authors:  Iyadh Douagi; Mattias N E Forsell; Christopher Sundling; Sijy O'Dell; Yu Feng; Pia Dosenovic; Yuxing Li; Robert Seder; Karin Loré; John R Mascola; Richard T Wyatt; Gunilla B Karlsson Hedestam
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

9.  A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals.

Authors:  Laura M Walker; Melissa D Simek; Frances Priddy; Johannes S Gach; Denise Wagner; Michael B Zwick; Sanjay K Phogat; Pascal Poignard; Dennis R Burton
Journal:  PLoS Pathog       Date:  2010-08-05       Impact factor: 6.823

10.  Characterization of plasmablasts in the blood of HIV-infected viremic individuals: evidence for nonspecific immune activation.

Authors:  Clarisa M Buckner; Susan Moir; Jason Ho; Wei Wang; Jacqueline G Posada; Lela Kardava; Emily K Funk; Amy K Nelson; Yuxing Li; Tae-Wook Chun; Anthony S Fauci
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.